O. Masri

The association between RDW and survival of patients with squamous cell carcinoma of the tongue. Simple, cheap and convenient?

P. Rajwa, M. Miszczyk, I. Jabłońska, 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy

W. Majewski, G. Goldner, R. Suwiński, 2022, Biomedicines.

The survival impact of significant delays between surgery and radiochemotherapy in glioblastoma patients: A retrospective analysis from a large tertiary center

A. Tukiendorf, R. Tarnawski, E. Nowicka, 2021, Journal of Clinical Neuroscience.

Prognostic Factors in Postoperative Radiotherapy for Prostate Cancer – Tertiary Center Experience

W. Majewski, A. Paradysz, L. Miszczyk, 2021, Radiology and oncology.

Effect of Ileal Transposition (IT) on Angiopoietin-Like Protein-8 (ANGPTL8) and Pentraxin (PTX3) Plasma Level in Sprague-Dawley Rats Fed High-Fat Diet (HFD)

M. Kukla, T. Sawczyn, J. Jochem, 2021, International journal of endocrinology.

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer

W. Majewski, P. Wojcieszek, M. Miszczyk, 2022, Journal of contemporary brachytherapy.

Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients.

W. Majewski, G. Goldner, R. Suwiński, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Rectum and Bladder Toxicity in Postoperative Prostate Bed Irradiation: Dose–Volume Parameters Analysis

P. Rajwa, Ł. Magrowski, O. Masri, 2023, Cancers.

Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.

G. Heilemann, R. Suwiński, P. Wojcieszek, 2024, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Does Brachytherapy Boost Improve Biochemical Control in Intermediate and High-Risk Prostate Cancer Patients Compared to External Beam Radiotherapy Alone?

W. Majewski, E. Nowicka, R. Suwiński, 2021, International journal of radiation oncology, biology, physics.